Accueil > Publications > MEVITEM: A European, randomized, open-label Phase I/II of vismodegib in combination with temozolomide versus temozolomide alone in adult patients with recurrent/ refractory medulloblastoma presenting an activation of the Sonic Hedgehog pathway

MEVITEM: A European, randomized, open-label Phase I/II of vismodegib in combination with temozolomid...